Literature DB >> 12056741

Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome.

Ko Watanabe1, Olivier Tournilhac, Lionel F Camilleri.   

Abstract

A 41-year old man, with idiopathic hypereosinophilic syndrome, had severe mitral regurgitation. He had two subsequent mechanical mitral valve thromboses in the setting of rising eosinophilia. A Carpentier-Edwards bioprosthesis was used for the third valve replacement. Some features of myeloproliferative disease, including chromosome 10 abnormality, were identified. A normal eosinophil count and disappearance of the chromosomal abnormality were obtained with interferon, hydroxyurea and prednisone therapy. At 30 months postoperatively, the patient had a normal lifestyle.

Entities:  

Mesh:

Year:  2002        PMID: 12056741

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

1.  Mitral and tricuspid valve repair in hypereosinophilic syndrome.

Authors:  Ahmed M Al-Kaisey; Zaal Meher-Homji; Philip Hayward; Elizabeth Jones
Journal:  BMJ Case Rep       Date:  2019-06-27

2.  Mitral valve destruction by Hodgkin's lymphoma-associated Loefler endocarditis.

Authors:  Sergey Yalonetsky; David Mishaly; Ayelet Ben-Barak; Avraham Lorber
Journal:  Pediatr Cardiol       Date:  2007-11-15       Impact factor: 1.655

3.  Recurrent prosthetic heart valve thrombosis secondary to eosinophilia: a missed diagnosis.

Authors:  Nitish Rai; Shyam S Kothari
Journal:  BMJ Case Rep       Date:  2017-10-03

Review 4.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

5.  Hypereosinophilia and Löffler's Endocarditis: A Systematic Review.

Authors:  Pramod Theetha Kariyanna; Naseem A Hossain; Neema Jayachamarajapura Onkaramurthy; Apoorva Jayarangaiah; Nimrah A Hossain; Amog Jayarangaiah; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2021-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.